Table 7. Diagnostic accuracies of APRI and FIB-4 for predicting liver fibrosis (Minimal-mild necroinflammation score 1–8, N = 1171).
Index | AUROCcutoff | Bootstrap AUROCcutoff | cutoff | sensitivitycutoff | specificitycutoff | PPVcutoff | NPVcutoff | Sensitivity + Specificity-1 |
---|---|---|---|---|---|---|---|---|
To predict fibrosis ≥2 | ||||||||
APRI | 0.63 (0.61–0.66) | 0.63 (0.61–0.66) | 1.0 | 43.6% | 83.1% | 66.9% | 65.3% | 27.9% |
FIB-4 | 0.65(0.63–0.67) | 0.65 (0.63–0.67) | 1.4 | 91.3% | 39.0% | 53.9% | 85.1% | 34.0% |
To predict fibrosis ≥3 | ||||||||
APRI | 0.67 (0.64–0.70) | 0.67 (0.64–0.70) | 1.4 | 69.7% | 64.3% | 51.5% | 79.6% | 34.0% |
FIB-4 | 0.71(0.69–0.74) | 0.71 (0.69–0.74) | 2.8 | 63.7% | 79.2% | 62.5% | 80.0% | 42.9% |
To predict fibrosis = 4 | ||||||||
APRI | 0.69 (0.66–0.72) | 0.69 (0.66–0.72) | 1.4 | 78.2% | 60.5% | 34.7% | 91.2% | 38.7% |
FIB-4 | 0.73(0.70–0.76) | 0.73 (0.70–0.76) | 2.8 | 72.6% | 73.9% | 2.8% | 90.9% | 48.0% |
APRI, aspartate aminotransferase (AST)- to-platelet ratio index; FIB-4, fibrosis index based on the four factors; AUROC, area under receiver operating characteristic